Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 50,983 | 51,139 | 48,430 | 47,769 | 46,688 |
| Cost of Goods | 2,073 | 1,189 | 1,494 | 1,370 | 1,725 |
| Gross Profit | 48,910 | 49,950 | 46,936 | 46,399 | 44,963 |
| Operating Expenses | 167,533 | 69,574 | 70,541 | 61,836 | 73,855 |
| Operating Income | -118,550 | -19,435 | -23,111 | -15,067 | -28,167 |
| Interest Expense | 4,762 | 4,767 | 4,634 | 4,887 | 4,599 |
| Other Income | 1,219 | 1,676 | 1,742 | 1,786 | 2,539 |
| Pre-tax Income | -122,093 | -22,526 | -26,003 | -18,168 | -30,227 |
| Income Tax | -471 | 23 | 65 | -18,976 | 32 |
| Net Income Continuous | -121,622 | -22,549 | -26,068 | 808 | -30,259 |
| Net Income | $-121,622 | $-22,549 | $-26,068 | $808 | $-30,259 |
| EPS Basic Total Ops | -2.56 | -0.44 | -0.58 | 0.02 | -0.70 |
| EPS Basic Continuous Ops | -2.56 | -0.44 | -0.58 | 0.02 | -0.70 |
| EPS Diluted Total Ops | -2.56 | -0.44 | -0.58 | 0.02 | -0.70 |
| EPS Diluted Continuous Ops | -2.56 | -0.44 | -0.58 | 0.02 | -0.70 |
| EBITDA(a) | $-109,758 | $-10,161 | $-14,465 | $-6,722 | $5,120 |